Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Vaccine|August 4, 2020
Safety evaluation of adverse events following vaccination with Havrix, Engerix-B or Twinrix during pregnancyFroilan Celzo, Hubert Buyse, Sarah Welby, et al.
Human Vaccines & Immunotherapeutics|September 20, 2013
The human rotavirus vaccine Rotarix™ in infants: an integrated analysis of safety and reactogenicityHubert Buyse, Carlota Vinals, Naveen Karkada, et al.
Drug Safety|January 11, 2016
Post-Marketing Benefit-Risk Assessment of Rotavirus Vaccination in Japan: A Simulation and Modelling AnalysisEdouard Ledent, Alfons Lieftucht, Hubert Buyse, et al.
Pharmacoepidemiology and Drug Safety|May 28, 2015
Post-marketing monitoring of intussusception after rotavirus vaccination in JapanVincent Bauchau, Lionel Van Holle, Olivia Mahaux, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|March 29, 2018
Benefit Versus Risk Assessment of Rotavirus Vaccination in France: A Simulation and Modeling AnalysisEdouard Ledent, Hugo Arlegui, Hubert Buyse, et al.
The Pediatric Infectious Disease Journal|June 13, 2015
Risk of Intussusception After Rotavirus Vaccination: Meta-analysis of Postlicensure StudiesDominique Rosillon, Hubert Buyse, Leonard R Friedland, et al.
Vaccine|May 4, 2017
Challenges in conducting post-authorisation safety studies (PASS): A vaccine manufacturer's viewCatherine Cohet, Dominique Rosillon, Corinne Willame, et al.
Pageof 1